ClariSigmam_Innovative Breast Cancer Prediction Marker

Breast Density Assessment Solution


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Brand name
ClariSigmam
Payment Terms
T/T
Production method
Available
Shipping / Lead Time
Negotiable / Negotiable
Keyword
breast, breast cancer, breast diagnostic chwalyounggi
Category
Ultrasound Scanner , Other Monitoring & Diagnostic Equipment

Claripi Inc.

Membership
BIZ
Country / Year Established
South Korea South Korea / 2015
Business type
Manufacturer

Exhibition 1

CES 2022
Verified Certificate

3

DUNS

Product name ClariSigmam_Innovative Breast Cancer Prediction Marker Certification -
Category Ultrasound Scanner
Other Monitoring & Diagnostic Equipment
Material -
Keyword breast , breast cancer , breast diagnostic chwalyounggi Unit Size -
Brand name ClariSigmam Unit Weigh -
origin South Korea Stock 1
Supply type Available HS code -

Product Information

ClariSigmam


The ClariSigmam is an innovative breast cancer prediction marker. 

It is a breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms. 

Quantitative breast density is the main indicator in breast cancer screening and diagnosis. The powerful pre-trained deep learning model ensures to make consistent clinical decision marking in an objective and convenient way. Novel Deep Learning Technology provides a fully automated quantification for breast and mammary area and proportion density measurements. 

With the world’s highest accuracy rate, ClariSigmam is convenient with a smart workflow at an affordable cost.

Benefits

1) Compliant with DICOM

; Compatible with multi vendor FFDM Scanner

2) Convenience

; Simplifies compliance with breast density notification laws

3) Accuracy

; World's highest accuracy rate of 97%

4) Help Predict the Risk

Unique color overlaid report allows easy verification of AI predicted tissue types




B2B Trade

Price (FOB) Negotiable transportation Negotiation Other
MOQ Negotiable Leadtime Negotiable
Payment Options T/T Shipping time Negotiable

Claripi Inc.

Country / Year Established
South Korea South Korea / 2015
Membership
BIZ
Business type
Manufacturer

Exhibition 1

CES 2022

3

DUNS

President
Kim Jong hyo
Address
(3F) 70-15Ihwajang-gil Jongno-gu South Korea, Jongno-gu, Seoul, Korea
Product Category
Other Monitoring & Diagnostic Equipment
Year Established
2015
Company introduction

ClariPi is an AI company that offers innovative medical imaging solutions through deep-learning and AI technology to change the standards of patient safety, making it our number one priority to reduce harmful health risks. Our products help patients get CT scans with radiation dose at virtually harmless level (1/10th of current practice) and yet produces high-quality images for diagnosis.

 

[Our Key Products]

 

* ClariCT.AI: provides powerful denoising and image clarity enabled by our signature AI-powered clarity engine. This product is to be paired with low-dose and ultra-low-dose CT scans to ensure the protection of patients and staff. 

 

* ClariPulmo: a fully automated AI-powered 3D reporting solution for emphysema and COVID-19 pneumonia. Our powerful pre-trained deep learning model provides accurate quantitative analysis of lung nodules as well as low-attenuation and high-attenuation lesions despite strong image noise and varying scanning conditions. It is best suited for low-dose lung CT screenings. Ask us how this product can help with COVID-19.

 

* ClariSIGMAM: a fully automated zero-click breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms. 

 

* ClariOsteo: an AI-powered precision bone healthcare solution with low-dose CT images. It uses existing CT scans and automatically provides analysis reports on spine fractures and osteoporosis risks which is useful for prevention and treatment management. 

 

* ClariACE: an AI-powered augmented contrast enhancing solution for low-dose CECT images. Our powerful pre-trained deep learning model selectively boosts contrast agent components in CT images without increasing contrast agent doses for patients. It clearly and selectively enhances the contrast of iodine without increasing noise in CT images. 

 

Our representative can give you a quick demo of these products as well as detailed image comparisons if you are interested. If you have any question, please message me or visit our website at www.claripi.com. 

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more